Effect of Swallowed Fluticasone Propionate on Eosinophilic Esophagitis; A Prospective, Randomized, Placebo-Controlled Trial
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fluticasone propionate (Primary)
- Indications Eosinophilic oesophagitis
- Focus Therapeutic Use
- Acronyms FAAN
- 11 Apr 2013 Biomarkers information updated
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Sep 2012 New trial record